Granja MG, Alves LP, Leardini-Tristo M, Saul ME, Bortoni LC, de Moraes FM, et al
Retatrutide produces 82-86% reductions in liver fat at 48 weeks, with 89-93% of participants achieving less than 5% liver fat (the threshold for resolution of fatty liver disease)
Liraglutide is a well-established GLP-1 medication that supports gradual and sustained weight loss when combined with healthy diet and exercise
With its ability to easily cross the blood-brain barrier and support healthy mitochondria and energy production in the brain, in addition to reducing oxidative damage and inflammation, ALCAR is proving to be a valuable neuroprotective supplement.
The spray format may offer advantages for those who prefer sublingual delivery or have difficulty swallowing capsules